twitter-longform-medical
Write data-driven, evidence-first long-form Twitter posts on medicine and cardiology. Use when the user wants to: (1) Create thought leadership content in the style of Eric Topol, Peter Attia, Andrew Huberman, or Rhonda Patrick, (2) Present clinical evidence with charts, data, and Q1 journal citations for educated non-specialist audiences, (3) Write confident, matter-of-fact medical content that is rigorous without being inaccessible, (4) Explain trials, drugs, or medical phenomena using data visualization and systematic evidence review, (5) Build authority through methodological rigor and clear conclusions backed by evidence. NOT for newsletters or Substack. For Twitter long-form posts only.
Installation
Follow the repository instructions for this skill and your agent. Review the files and dependencies before adding it to your workflow.
View source ↗GuidesSkill instructions
Features and purpose
Write data-driven, evidence-first long-form Twitter posts on medicine and cardiology. Use when the user wants to: (1) Create thought leadership content in the style of Eric Topol, Peter Attia, Andrew Huberman, or Rhonda Patrick, (2) Present clinical evidence with charts, data, and Q1 journal citations for educated non-specialist audiences, (3) Write confident, matter-of-fact medical content that is rigorous without being inaccessible, (4) Explain trials, drugs, or medical phenomena using data visualization and systematic evidence review, (5) Build authority through methodological rigor and clear conclusions backed by evidence. NOT for newsletters or Substack. For Twitter long-form posts only.
Quick start
Follow the repository instructions for this skill and your agent. Review the files and dependencies before adding it to your workflow.
Guides ↗Examples
Read the usage examples in the source repository.
View source ↗Source history
- Indexed on
- 2026-01-20
- Index updated
- 2026-02-26
- Branch
- main
Index and sync dates describe this directory. View the source repository for code history.
GitHub ↗chat Comments (0)
Sign in to join the discussion and leave a comment.
No comments yet. Be the first to share your thoughts!